Immunogenicity and safety of an 18-month booster dose of the VLA15 Lyme borreliosis vaccine candidate after primary immunisation in healthy adults in the USA: results of the booster phase of a randomised, controlled, phase 2 trial
Titel:
Immunogenicity and safety of an 18-month booster dose of the VLA15 Lyme borreliosis vaccine candidate after primary immunisation in healthy adults in the USA: results of the booster phase of a randomised, controlled, phase 2 trial
Auteur:
Ghadge, Santhosh Kumar Schneider, Martina Dubischar, Katrin Wagner, Laura Kadlecek, Vera Obersriebnig, Michaela Hochreiter, Romana Klingler, Anton Larcher-Senn, Julian Derhaschnig, Ulla Bender, Wolfgang Eder-Lingelbach, Susanne Bézay, Nicole